Venous thromboembolism in COPD hospitalized patients
- PMID: 22016148
- DOI: 10.1007/s11239-011-0646-x
Venous thromboembolism in COPD hospitalized patients
Abstract
Patients with chronic obstructive pulmonary disease (COPD) are at increased risk for venous thromboembolism (VTE). We analyzed a large Spanish database to determine the incidence of VTE in these patients during hospitalization. A retrospective chart review of cohort of consecutive patients admitted with COPD as the primary reason for discharge in Spain between January 1st 2006 and December 31st 2007 was performed. For each patient, demographic data, risk factors for VTE and the diagnosis of VTE during hospitalization was recorded. We analyzed the clinical data of 313,233 adults with acute exacerbations of COPD admitted to the hospital at any public centre in Spain, in 2006 and 2007. We identify 3,562 new diagnosed VTE events among 270,840 COPD patients hospitalized more than two days (incidence 1.32%). Hospitalized-acquired VTE risk factors were male gender (odds ratio [OR] 1.77; CI95% 1.66-1.90), neoplasic disease (OR 2.93 CI95% 2.69-3.16, systemic arterial disease (OR 1.17 CI95% 1.10-1.36), decubitus ulcer (OR 1.19 CI95% 1.01-1.43), diabetes (OR 0.74 IC95% 0.69-0.81), and atrial fibrillation (OR 0.79 CI95% 0.72-0.87). VTE appears as a major threat to patients admitted for acute exacerbation of COPD, and pharmacologic prophylaxis should be considered in all high risk situations.
Similar articles
-
[Proportion and prevention of venous thromboembolism among hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Beijing].Zhonghua Yi Xue Za Zhi. 2013 Aug 13;93(30):2337-40. Zhonghua Yi Xue Za Zhi. 2013. PMID: 24300197 Chinese.
-
Association between features of COPD and risk of venous thromboembolism.Clin Respir J. 2019 Aug;13(8):499-504. doi: 10.1111/crj.13051. Epub 2019 Jun 7. Clin Respir J. 2019. PMID: 31172658
-
The prevalence and risk factors of venous thromboembolism in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease.Clin Respir J. 2018 Nov;12(11):2573-2580. doi: 10.1111/crj.12959. Epub 2018 Oct 22. Clin Respir J. 2018. PMID: 30207643
-
[Prophylaxis of venous thromboembolism in patients with chronic obstructive pulmonary disease].Klin Med (Mosk). 2011;89(6):4-8. Klin Med (Mosk). 2011. PMID: 22420186 Review. Russian.
-
Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD.Thromb Res. 2003;112(4):203-7. doi: 10.1016/j.thromres.2003.12.003. Thromb Res. 2003. PMID: 14987912 Review.
Cited by
-
Effects of simvastatin on tissue factor pathway of blood coagulation in STATCOPE (Simvastatin in the prevention of COPD exacerbations) trial.J Thromb Haemost. 2021 Jul;19(7):1709-1717. doi: 10.1111/jth.15282. Epub 2021 Apr 12. J Thromb Haemost. 2021. PMID: 33638931 Free PMC article. Clinical Trial.
-
Risk Factors for Venous Thromboembolism Among Reproductive Age Women.J Womens Health (Larchmt). 2016 Jan;25(1):63-70. doi: 10.1089/jwh.2015.5259. Epub 2015 Aug 28. J Womens Health (Larchmt). 2016. PMID: 26317174 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical